πŸ‡ΊπŸ‡Έ FDA
Patent

US 12110502

Models of tauopathy

granted A61KA61K48/0058A61K9/0019

Quick answer

US patent 12110502 (Models of tauopathy) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K48/0058, A61K9/0019